Transaction made with intent to develop new drugs, company says.Kyowa Kirin Co., Ltd announced in a company press release that it will officially acquire Orchard Therapeutics for the price of $16 per American depository share (ADS) in cash, equaling a total of $387.4 million. Orchard shareholders will hold an additional contingent value right (CVR) of […]
